Table: Kringle Pharma - Q1 parent results

Kringle Pharma

10/02/2023 06:40

Feb 10 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Dec 31, 2022        Dec 31, 2021       Sep 30, 2023  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            17 mln              13 mln             68 mln     
                 (+25.8 pct)         (-85.4 pct)       (-82.4 pct)   
  Operating     loss 157 mln        loss 120 mln       loss 993 mln  
  Recurring     loss 157 mln        loss 128 mln       loss 953 mln  
  Net           loss 157 mln        loss 129 mln       loss 955 mln  
  EPS          loss 29.34 yen      loss 29.02 yen    loss 177.50 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T